Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/03/012508
CTRI/2018/03/012508
Recruiting
N/A

Prospective Validation of Prediction algorithms for Preeclampsia in the first, second and third Trimesters of pregnancy

iona Chiu Yee Poon0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
iona Chiu Yee Poon
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
iona Chiu Yee Poon

Eligibility Criteria

Inclusion Criteria

  • •singleton pregnancy with live fetus
  • •those who sign the Informed Consent Form

Exclusion Criteria

  • •multiple pregnancy, non viable fetus and not signing the consent form

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
Development and validation of prediction models for treatment failure of HFNC in COVID-19: a multicenter cohort studyCOVID-19
JPRN-UMIN000050024Tohoku University300
Completed
N/A
Prospective validation of a predictive model for pathologic complete response after chemoradiotherapy in rectal cancer: A prognostic studycancer of the rectum/rectumcancer1000211210017991
NL-OMON33076MAASTRO clinic60
Completed
N/A
Validating Artificial Intelligence Predictions of Postoperative Delirium after Cardiac SurgeryPostoperative DeliriumF05.0Delirium not superimposed on dementia, so described
DRKS00028749Institut für Anästhesiologie und SchmerztherapieHerz- und Diabeteszentrum NRW393
Completed
N/A
Prospective study of evaluation to the predictive biomarker of Nivolumab by tumor tissue specimen and neighboring bronchoaveolar lavage fluid (BALF) and Blood
JPRN-UMIN000023822Respiratory Medicine, Allergy and Rheumatic Diseases Osaka University Graduate School of Medicine20
Active, Not Recruiting
Phase 1
Assessment of a predictive response model for romiplostim in patients with low or intermediate-1 risk myelodysplastic syndrome (MDS) and thrombocytopenia - the EUROPE-trialPatients with IPSS low or intermediate-1 risk myelodysplastic syndrome (MDS) and thrombocytopeniaMedDRA version: 18.1Level: LLTClassification code 10068361Term: MDSSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2013-004328-12-FRGMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie mbH90